Understanding in depth how tumors evolve to become malignant is the objective of a study recently published in the journal ...

Alphamab Oncology (stock code: 9966 HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (stock code: 1093.HK) jointly announced that an application for a phase III clinical study (Study ID: KN026-004 ...

The Broncos’ support was truly overwhelming. They have gone above and beyond, and it’s hard to put into words what it means ...

Brain tumors present a significant global health challenge, with over 300,000 new cases reported annually worldwide ...

【导读】非小细胞肺癌(NSCLC)通常在晚期被诊断出来，这限制了治疗干预的有效性。本研究旨在探讨新发现的circLIFRSA在PTEN/AKT信号通路中的作用及其在非小细胞肺癌恶性过程中的作用。9月28日，宁波大学研究团队在期刊《Molecular ...

Along with the risks of radiation exposure in mammography, ethical concerns abound with the use of AI in breast cancer ...

Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal ...

For the first time in Bulgaria, an 11-year-old girl will regain movement in her shoulder and arm following a groundbreaking ...

Malignant cells down-regulate cell death by overexpressing a transcription factor called BCL6. “Our idea was to borrow a little bit of the activity of the kinase and drag it over to where BCL6 is ...

Given the success of the first edition of Altered Metabolic Traits in Gastrointestinal Tract Cancers, we are pleased to ...

These breakthrough therapies have not only improved survival rates but also provided more targeted, less invasive options.

Breakthrough research sheds light on the genetic mutation behind aggressive prostate cancer. Study: CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and ...